Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Insulin Needle-free Injection Pen was estimated to be worth US$ 286 million in 2025 and is projected to reach US$ 406 million, growing at a CAGR of 5.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Needle-free Injection Pen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Insulin Needle-free Injection Pen Market Size(US$)
M= millions and B=billions

In 2024, the global production of Insulin Needle-free Injection Pen will reach 544,100 units, with an average selling price of US$500 per unit. The needle-free injection pen contains a spring-loaded or compressed gas (such as carbon dioxide) mechanism that is used to generate high pressure. When the user presses the trigger button of the injection pen, the internal mechanism is activated, causing the high-pressure gas to rapidly propel the drug. The propulsion of the high-pressure gas causes the drug to form an extremely fine liquid jet, which penetrates the surface layer of the skin at an extremely high speed, usually forming micropores in the epidermis or dermis without causing much pain or trauma. Drug delivery can be completed without a needle, providing a nearly painless injection experience, which greatly reduces patients' injection anxiety. The Insulin Needle-free Injection Pen is a medical device that uses physical pressure or ultrasonic technology to spray insulin in a micronized form directly into the subcutaneous tissue, completely abandoning the traditional needle puncture method.
The North American market for Insulin Needle-free Injection Pen was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Insulin Needle-free Injection Pen was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Insulin Needle-free Injection Pen was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Insulin Needle-free Injection Pen market include Portal Instruments, Injex Pharma, JSK Biomed, Glide Pharma, Antares Pharma, Inc., InsuJet, Miracle Medical, Crossject SA, PharmaJet, Mika Medical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Insulin Needle-free Injection Pen, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Insulin Needle-free Injection Pen market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Insulin Needle-free Injection Pen.
Market Segmentation
Report Metric
Details
Report Title
Insulin Needle-free Injection Pen- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 406 million
CAGR(2026-2032)
5.2%
Market Size Available for Years
2026-2032
Global Insulin Needle-free Injection Pen Companies Covered
Portal Instruments
Injex Pharma
JSK Biomed
Glide Pharma
Antares Pharma, Inc.
InsuJet
Miracle Medical
Crossject SA
PharmaJet
Mika Medical
Lepu Medical Technology (Beijing) Co., Ltd.
Shandong Zhongbaokang Medical Equipment Co.,Ltd
Jiangxi Sanxin Medtec Co.,Ltd.
Quinovare
Joyomed Suzhou Co.,Ltd.
Sinocare
Global Insulin Needle-free Injection Pen Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Needle-free Injection Pen Market, Segment by Type
Mechanical Force
Electric Force
Optical Force
Global Insulin Needle-free Injection Pen Market, Segment by Application
Hospital & Clinic
Retail Pharmacies
Online Channel
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Insulin Needle-free Injection Pen manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Insulin Needle-free Injection Pen sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Insulin Needle-free Injection Pen sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Insulin Needle-free Injection Pen Product Introduction
1.2 Global Insulin Needle-free Injection Pen Market Size Forecast
1.2.1 Global Insulin Needle-free Injection Pen Sales Value (2021–2032)
1.2.2 Global Insulin Needle-free Injection Pen Sales Volume (2021–2032)
1.2.3 Global Insulin Needle-free Injection Pen Sales Price (2021–2032)
1.3 Insulin Needle-free Injection Pen Market Trends & Drivers
1.3.1 Insulin Needle-free Injection Pen Industry Trends
1.3.2 Insulin Needle-free Injection Pen Market Drivers & Opportunities
1.3.3 Insulin Needle-free Injection Pen Market Challenges
1.3.4 Insulin Needle-free Injection Pen Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Needle-free Injection Pen Players Revenue Ranking (2025)
2.2 Global Insulin Needle-free Injection Pen Revenue by Company (2021–2026)
2.3 Global Insulin Needle-free Injection Pen Sales Volume Ranking of Players (2025)
2.4 Global Insulin Needle-free Injection Pen Sales Volume by Company (2021–2026)
2.5 Global Insulin Needle-free Injection Pen Average Price by Company (2021–2026)
2.6 Key Manufacturers Insulin Needle-free Injection Pen Manufacturing Base and Headquarters
2.7 Key Manufacturers Insulin Needle-free Injection Pen Product Offerings
2.8 Key Manufacturers Start of Mass Production of Insulin Needle-free Injection Pen
2.9 Insulin Needle-free Injection Pen Market Competitive Analysis
2.9.1 Insulin Needle-free Injection Pen Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Needle-free Injection Pen Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Insulin Needle-free Injection Pen revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Insulin Needle-free Injection Pen Market Classification
3.1 Introduction by Type
3.1.1 Mechanical Force
3.1.2 Electric Force
3.1.3 Optical Force
3.1.4 Global Insulin Needle-free Injection Pen Sales Value by Type
3.1.4.1 Global Insulin Needle-free Injection Pen Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Insulin Needle-free Injection Pen Sales Value, by Type (2021–2032)
3.1.4.3 Global Insulin Needle-free Injection Pen Sales Value, by Type (%), 2021–2032
3.1.5 Global Insulin Needle-free Injection Pen Sales Volume by Type
3.1.5.1 Global Insulin Needle-free Injection Pen Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Insulin Needle-free Injection Pen Sales Volume, by Type (2021–2032)
3.1.5.3 Global Insulin Needle-free Injection Pen Sales Volume, by Type (%), 2021–2032
3.1.6 Global Insulin Needle-free Injection Pen Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital & Clinic
4.1.2 Retail Pharmacies
4.1.3 Online Channel
4.2 Global Insulin Needle-free Injection Pen Sales Value by Application
4.2.1 Global Insulin Needle-free Injection Pen Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Insulin Needle-free Injection Pen Sales Value, by Application (2021–2032)
4.2.3 Global Insulin Needle-free Injection Pen Sales Value, by Application (%), 2021–2032
4.3 Global Insulin Needle-free Injection Pen Sales Volume by Application
4.3.1 Global Insulin Needle-free Injection Pen Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Insulin Needle-free Injection Pen Sales Volume, by Application (2021–2032)
4.3.3 Global Insulin Needle-free Injection Pen Sales Volume, by Application (%), 2021–2032
4.4 Global Insulin Needle-free Injection Pen Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Insulin Needle-free Injection Pen Sales Value by Region
5.1.1 Global Insulin Needle-free Injection Pen Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Insulin Needle-free Injection Pen Sales Value by Region (2021–2026)
5.1.3 Global Insulin Needle-free Injection Pen Sales Value by Region (2027–2032)
5.1.4 Global Insulin Needle-free Injection Pen Sales Value by Region (%), 2021–2032
5.2 Global Insulin Needle-free Injection Pen Sales Volume by Region
5.2.1 Global Insulin Needle-free Injection Pen Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Insulin Needle-free Injection Pen Sales Volume by Region (2021–2026)
5.2.3 Global Insulin Needle-free Injection Pen Sales Volume by Region (2027–2032)
5.2.4 Global Insulin Needle-free Injection Pen Sales Volume by Region (%), 2021–2032
5.3 Global Insulin Needle-free Injection Pen Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Insulin Needle-free Injection Pen Sales Value, 2021–2032
5.4.2 North America Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Insulin Needle-free Injection Pen Sales Value, 2021–2032
5.5.2 Europe Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Needle-free Injection Pen Sales Value, 2021–2032
5.6.2 Asia Pacific Insulin Needle-free Injection Pen Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Insulin Needle-free Injection Pen Sales Value, 2021–2032
5.7.2 South America Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Needle-free Injection Pen Sales Value, 2021–2032
5.8.2 Middle East & Africa Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Needle-free Injection Pen Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Insulin Needle-free Injection Pen Sales Value and Sales Volume
6.2.1 Key Countries/Regions Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.2.2 Key Countries/Regions Insulin Needle-free Injection Pen Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.3.2 United States Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.4.2 Europe Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.5.2 China Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.5.3 China Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.6.2 Japan Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.7.2 South Korea Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.8.2 Southeast Asia Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Insulin Needle-free Injection Pen Sales Value, 2021–2032
6.9.2 India Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
6.9.3 India Insulin Needle-free Injection Pen Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Portal Instruments
7.1.1 Portal Instruments Company Information
7.1.2 Portal Instruments Introduction and Business Overview
7.1.3 Portal Instruments Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Portal Instruments Insulin Needle-free Injection Pen Product Offerings
7.1.5 Portal Instruments Recent Developments
7.2 Injex Pharma
7.2.1 Injex Pharma Company Information
7.2.2 Injex Pharma Introduction and Business Overview
7.2.3 Injex Pharma Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Injex Pharma Insulin Needle-free Injection Pen Product Offerings
7.2.5 Injex Pharma Recent Developments
7.3 JSK Biomed
7.3.1 JSK Biomed Company Information
7.3.2 JSK Biomed Introduction and Business Overview
7.3.3 JSK Biomed Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 JSK Biomed Insulin Needle-free Injection Pen Product Offerings
7.3.5 JSK Biomed Recent Developments
7.4 Glide Pharma
7.4.1 Glide Pharma Company Information
7.4.2 Glide Pharma Introduction and Business Overview
7.4.3 Glide Pharma Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Glide Pharma Insulin Needle-free Injection Pen Product Offerings
7.4.5 Glide Pharma Recent Developments
7.5 Antares Pharma, Inc.
7.5.1 Antares Pharma, Inc. Company Information
7.5.2 Antares Pharma, Inc. Introduction and Business Overview
7.5.3 Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Offerings
7.5.5 Antares Pharma, Inc. Recent Developments
7.6 InsuJet
7.6.1 InsuJet Company Information
7.6.2 InsuJet Introduction and Business Overview
7.6.3 InsuJet Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 InsuJet Insulin Needle-free Injection Pen Product Offerings
7.6.5 InsuJet Recent Developments
7.7 Miracle Medical
7.7.1 Miracle Medical Company Information
7.7.2 Miracle Medical Introduction and Business Overview
7.7.3 Miracle Medical Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Miracle Medical Insulin Needle-free Injection Pen Product Offerings
7.7.5 Miracle Medical Recent Developments
7.8 Crossject SA
7.8.1 Crossject SA Company Information
7.8.2 Crossject SA Introduction and Business Overview
7.8.3 Crossject SA Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Crossject SA Insulin Needle-free Injection Pen Product Offerings
7.8.5 Crossject SA Recent Developments
7.9 PharmaJet
7.9.1 PharmaJet Company Information
7.9.2 PharmaJet Introduction and Business Overview
7.9.3 PharmaJet Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 PharmaJet Insulin Needle-free Injection Pen Product Offerings
7.9.5 PharmaJet Recent Developments
7.10 Mika Medical
7.10.1 Mika Medical Company Information
7.10.2 Mika Medical Introduction and Business Overview
7.10.3 Mika Medical Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Mika Medical Insulin Needle-free Injection Pen Product Offerings
7.10.5 Mika Medical Recent Developments
7.11 Lepu Medical Technology (Beijing) Co., Ltd.
7.11.1 Lepu Medical Technology (Beijing) Co., Ltd. Company Information
7.11.2 Lepu Medical Technology (Beijing) Co., Ltd. Introduction and Business Overview
7.11.3 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Offerings
7.11.5 Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
7.12 Shandong Zhongbaokang Medical Equipment Co.,Ltd
7.12.1 Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
7.12.2 Shandong Zhongbaokang Medical Equipment Co.,Ltd Introduction and Business Overview
7.12.3 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Offerings
7.12.5 Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
7.13 Jiangxi Sanxin Medtec Co.,Ltd.
7.13.1 Jiangxi Sanxin Medtec Co.,Ltd. Company Information
7.13.2 Jiangxi Sanxin Medtec Co.,Ltd. Introduction and Business Overview
7.13.3 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Offerings
7.13.5 Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
7.14 Quinovare
7.14.1 Quinovare Company Information
7.14.2 Quinovare Introduction and Business Overview
7.14.3 Quinovare Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Quinovare Insulin Needle-free Injection Pen Product Offerings
7.14.5 Quinovare Recent Developments
7.15 Joyomed Suzhou Co.,Ltd.
7.15.1 Joyomed Suzhou Co.,Ltd. Company Information
7.15.2 Joyomed Suzhou Co.,Ltd. Introduction and Business Overview
7.15.3 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Offerings
7.15.5 Joyomed Suzhou Co.,Ltd. Recent Developments
7.16 Sinocare
7.16.1 Sinocare Company Information
7.16.2 Sinocare Introduction and Business Overview
7.16.3 Sinocare Insulin Needle-free Injection Pen Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Sinocare Insulin Needle-free Injection Pen Product Offerings
7.16.5 Sinocare Recent Developments
8 Industry Chain Analysis
8.1 Insulin Needle-free Injection Pen Industrial Chain
8.2 Insulin Needle-free Injection Pen Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Insulin Needle-free Injection Pen Sales Model
8.5.2 Sales Channels
8.5.3 Insulin Needle-free Injection Pen Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Insulin Needle-free Injection Pen Market Trends
Table 2. Insulin Needle-free Injection Pen Market Drivers & Opportunities
Table 3. Insulin Needle-free Injection Pen Market Challenges
Table 4. Insulin Needle-free Injection Pen Market Restraints
Table 5. Global Insulin Needle-free Injection Pen Revenue by Company (US$ Million), 2021–2026
Table 6. Global Insulin Needle-free Injection Pen Revenue Market Share by Company (2021–2026)
Table 7. Global Insulin Needle-free Injection Pen Sales Volume by Company (K Units), 2021–2026
Table 8. Global Insulin Needle-free Injection Pen Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Insulin Needle-free Injection Pen Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Insulin Needle-free Injection Pen Manufacturing Base and Headquarters
Table 11. Key Manufacturers Insulin Needle-free Injection Pen Product Type
Table 12. Key Manufacturers Start of Mass Production of Insulin Needle-free Injection Pen
Table 13. Global Insulin Needle-free Injection Pen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Insulin Needle-free Injection Pen revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Insulin Needle-free Injection Pen Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Insulin Needle-free Injection Pen Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Insulin Needle-free Injection Pen Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Insulin Needle-free Injection Pen Sales Market Share in Value by Type (2021–2026)
Table 20. Global Insulin Needle-free Injection Pen Sales Market Share in Value by Type (2027–2032)
Table 21. Global Insulin Needle-free Injection Pen Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Insulin Needle-free Injection Pen Sales Volume by Type (K Units), 2021–2026
Table 23. Global Insulin Needle-free Injection Pen Sales Volume by Type (K Units), 2027–2032
Table 24. Global Insulin Needle-free Injection Pen Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Insulin Needle-free Injection Pen Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Insulin Needle-free Injection Pen Price by Type (US$/Unit), 2021–2026
Table 27. Global Insulin Needle-free Injection Pen Price by Type (US$/Unit), 2027–2032
Table 28. Global Insulin Needle-free Injection Pen Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Insulin Needle-free Injection Pen Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Insulin Needle-free Injection Pen Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Insulin Needle-free Injection Pen Sales Market Share in Value by Application (2021–2026)
Table 32. Global Insulin Needle-free Injection Pen Sales Market Share in Value by Application (2027–2032)
Table 33. Global Insulin Needle-free Injection Pen Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Insulin Needle-free Injection Pen Sales Volume by Application (K Units), 2021–2026
Table 35. Global Insulin Needle-free Injection Pen Sales Volume by Application (K Units), 2027–2032
Table 36. Global Insulin Needle-free Injection Pen Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Insulin Needle-free Injection Pen Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Insulin Needle-free Injection Pen Price by Application (US$/Unit), 2021–2026
Table 39. Global Insulin Needle-free Injection Pen Price by Application (US$/Unit), 2027–2032
Table 40. Global Insulin Needle-free Injection Pen Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Insulin Needle-free Injection Pen Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Insulin Needle-free Injection Pen Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Insulin Needle-free Injection Pen Sales Value by Region (%), 2021–2026
Table 44. Global Insulin Needle-free Injection Pen Sales Value by Region (%), 2027–2032
Table 45. Global Insulin Needle-free Injection Pen Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Insulin Needle-free Injection Pen Sales Volume by Region (K Units), 2021–2026
Table 47. Global Insulin Needle-free Injection Pen Sales Volume by Region (K Units), 2027–2032
Table 48. Global Insulin Needle-free Injection Pen Sales Volume by Region (%), 2021–2026
Table 49. Global Insulin Needle-free Injection Pen Sales Volume by Region (%), 2027–2032
Table 50. Global Insulin Needle-free Injection Pen Average Price by Region (US$/Unit), 2021–2026
Table 51. Global Insulin Needle-free Injection Pen Average Price by Region (US$/Unit), 2027–2032
Table 52. Key Countries/Regions Insulin Needle-free Injection Pen Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Insulin Needle-free Injection Pen Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Insulin Needle-free Injection Pen Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Insulin Needle-free Injection Pen Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Insulin Needle-free Injection Pen Sales Volume, (K Units), 2027–2032
Table 57. Portal Instruments Company Information
Table 58. Portal Instruments Introduction and Business Overview
Table 59. Portal Instruments Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 60. Portal Instruments Insulin Needle-free Injection Pen Product Offerings
Table 61. Portal Instruments Recent Developments
Table 62. Injex Pharma Company Information
Table 63. Injex Pharma Introduction and Business Overview
Table 64. Injex Pharma Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 65. Injex Pharma Insulin Needle-free Injection Pen Product Offerings
Table 66. Injex Pharma Recent Developments
Table 67. JSK Biomed Company Information
Table 68. JSK Biomed Introduction and Business Overview
Table 69. JSK Biomed Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 70. JSK Biomed Insulin Needle-free Injection Pen Product Offerings
Table 71. JSK Biomed Recent Developments
Table 72. Glide Pharma Company Information
Table 73. Glide Pharma Introduction and Business Overview
Table 74. Glide Pharma Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 75. Glide Pharma Insulin Needle-free Injection Pen Product Offerings
Table 76. Glide Pharma Recent Developments
Table 77. Antares Pharma, Inc. Company Information
Table 78. Antares Pharma, Inc. Introduction and Business Overview
Table 79. Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 80. Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Offerings
Table 81. Antares Pharma, Inc. Recent Developments
Table 82. InsuJet Company Information
Table 83. InsuJet Introduction and Business Overview
Table 84. InsuJet Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 85. InsuJet Insulin Needle-free Injection Pen Product Offerings
Table 86. InsuJet Recent Developments
Table 87. Miracle Medical Company Information
Table 88. Miracle Medical Introduction and Business Overview
Table 89. Miracle Medical Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 90. Miracle Medical Insulin Needle-free Injection Pen Product Offerings
Table 91. Miracle Medical Recent Developments
Table 92. Crossject SA Company Information
Table 93. Crossject SA Introduction and Business Overview
Table 94. Crossject SA Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 95. Crossject SA Insulin Needle-free Injection Pen Product Offerings
Table 96. Crossject SA Recent Developments
Table 97. PharmaJet Company Information
Table 98. PharmaJet Introduction and Business Overview
Table 99. PharmaJet Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 100. PharmaJet Insulin Needle-free Injection Pen Product Offerings
Table 101. PharmaJet Recent Developments
Table 102. Mika Medical Company Information
Table 103. Mika Medical Introduction and Business Overview
Table 104. Mika Medical Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 105. Mika Medical Insulin Needle-free Injection Pen Product Offerings
Table 106. Mika Medical Recent Developments
Table 107. Lepu Medical Technology (Beijing) Co., Ltd. Company Information
Table 108. Lepu Medical Technology (Beijing) Co., Ltd. Introduction and Business Overview
Table 109. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 110. Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Offerings
Table 111. Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
Table 112. Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
Table 113. Shandong Zhongbaokang Medical Equipment Co.,Ltd Introduction and Business Overview
Table 114. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 115. Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Offerings
Table 116. Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
Table 117. Jiangxi Sanxin Medtec Co.,Ltd. Company Information
Table 118. Jiangxi Sanxin Medtec Co.,Ltd. Introduction and Business Overview
Table 119. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 120. Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Offerings
Table 121. Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
Table 122. Quinovare Company Information
Table 123. Quinovare Introduction and Business Overview
Table 124. Quinovare Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 125. Quinovare Insulin Needle-free Injection Pen Product Offerings
Table 126. Quinovare Recent Developments
Table 127. Joyomed Suzhou Co.,Ltd. Company Information
Table 128. Joyomed Suzhou Co.,Ltd. Introduction and Business Overview
Table 129. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 130. Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Offerings
Table 131. Joyomed Suzhou Co.,Ltd. Recent Developments
Table 132. Sinocare Company Information
Table 133. Sinocare Introduction and Business Overview
Table 134. Sinocare Insulin Needle-free Injection Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 135. Sinocare Insulin Needle-free Injection Pen Product Offerings
Table 136. Sinocare Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Key Suppliers of Raw Materials Lists
Table 139. Insulin Needle-free Injection Pen Downstream Customers
Table 140. Insulin Needle-free Injection Pen Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Needle-free Injection Pen Product Picture
Figure 2. Global Insulin Needle-free Injection Pen Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 4. Global Insulin Needle-free Injection Pen Sales Volume (K Units), 2021–2032
Figure 5. Global Insulin Needle-free Injection Pen Sales Price (US$/Unit), 2021–2032
Figure 6. Insulin Needle-free Injection Pen Report Years Considered
Figure 7. Global Insulin Needle-free Injection Pen Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Insulin Needle-free Injection Pen Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Needle-free Injection Pen Revenue in 2025
Figure 10. Insulin Needle-free Injection Pen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Mechanical Force Picture
Figure 12. Electric Force Picture
Figure 13. Optical Force Picture
Figure 14. Global Insulin Needle-free Injection Pen Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Insulin Needle-free Injection Pen Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Insulin Needle-free Injection Pen Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 17. Global Insulin Needle-free Injection Pen Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Insulin Needle-free Injection Pen Price by Type (US$/Unit), 2021–2032
Figure 19. Product Picture of Hospital & Clinic
Figure 20. Product Picture of Retail Pharmacies
Figure 21. Product Picture of Online Channel
Figure 22. Global Insulin Needle-free Injection Pen Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Insulin Needle-free Injection Pen Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Insulin Needle-free Injection Pen Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 25. Global Insulin Needle-free Injection Pen Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Insulin Needle-free Injection Pen Price by Application (US$/Unit), 2021–2032
Figure 27. North America Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 28. North America Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 30. Europe Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Insulin Needle-free Injection Pen Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 34. South America Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Insulin Needle-free Injection Pen Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Insulin Needle-free Injection Pen Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Insulin Needle-free Injection Pen Sales Volume (%), 2021–2032
Figure 39. United States Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 40. United States Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 43. Europe Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 45. China Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 46. China Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 47. China Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 49. Japan Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 57. India Insulin Needle-free Injection Pen Sales Value (US$ Million), 2021–2032
Figure 58. India Insulin Needle-free Injection Pen Sales Value by Type (%), 2025 vs 2032
Figure 59. India Insulin Needle-free Injection Pen Sales Value by Application (%), 2025 vs 2032
Figure 60. Insulin Needle-free Injection Pen Industrial Chain
Figure 61. Insulin Needle-free Injection Pen Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Insulin Needle-free Injection Pen was estimated to be worth US$ 286 million in 2025 and is projected to reach US$ 406 million, growing at a CAGR of 5.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Needle-free Injection Pen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of Insulin Needle-free Injection Pen will reach 544,100 units, with an average selling price of US$500 per unit. The needle-free injection pen contains a spring-loaded or compressed gas (such as carbon dioxide) mechanism that is used to generate high pressure. When the user presses the trigger button of the injection pen, the internal mechanism is activated, causing the high-pressure gas to rapidly propel the drug. The propulsion of the high-pressure gas causes the drug to form an extremely fine liquid jet, which penetrates the surface layer of the skin at an extremely high speed, usually forming micropores in the epidermis or dermis without causing much pain or trauma. Drug delivery can be completed without a needle, providing a nearly painless injection experience, which greatly reduces patients' injection anxiety. The Insulin Needle-free Injection Pen is a medical device that uses physical pressure or ultrasonic technology to spray insulin in a micronized form directly into the subcutaneous tissue, completely abandoning the traditional needle puncture method.
The North American market for Insulin Needle-free Injection Pen was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Insulin Needle-free Injection Pen was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Insulin Needle-free Injection Pen was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Insulin Needle-free Injection Pen market include Portal Instruments, Injex Pharma, JSK Biomed, Glide Pharma, Antares Pharma, Inc., InsuJet, Miracle Medical, Crossject SA, PharmaJet, Mika Medical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Insulin Needle-free Injection Pen, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Insulin Needle-free Injection Pen market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Insulin Needle-free Injection Pen.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Insulin Needle-free Injection Pen manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Insulin Needle-free Injection Pen sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Insulin Needle-free Injection Pen sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Related Reports
The global Insulin Needle-free Injection Pen market size was US$ 272 million in 2024 and is forecast to a readjusted size of US$ 388 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-08-29
Pages: 103
USD 4250.00
(Single User License)
The global market for Insulin Needle-free Injection Pen was estimated to be worth US$ 272 million in 2024 and is forecast to a readjusted size of US$ 388 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-08-29
Pages: 142
USD 3950.00
(Single User License)
The global market for Insulin Needle-free Injection Pen was valued at US$ 272 million in the year 2024 and is projected to reach a revised size of US$ 388 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-08-29
Pages: 99
USD 2900.00
(Single User License)
The global Insulin Needle-free Injection Pen market is projected to grow from US$ 272 million in 2024 to US$ 388 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-29
Pages: 175
USD 4900.00
(Single User License)
The global Insulin Needle-free Injection Pen market was valued at US$ 286 million in 2025 and is anticipated to reach US$ 406 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
USD 2900.00
(Single User License)
The global Insulin Needle-free Injection Pen market size was US$ 286 million in 2025 and is forecast to reach a readjusted size of US$ 406 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 108
USD 4250.00
(Single User License)
The global Insulin Needle-free Injection Pen market is projected to grow from US$ 286 million in 2025 to US$ 406 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 176
USD 4900.00
(Single User License)
The global Insulin Needle-free Injection Pen market size was US$ 272 million in 2024 and is forecast to a readjusted size of US$ 388 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-08-29
Pages: 103
The global market for Insulin Needle-free Injection Pen was estimated to be worth US$ 272 million in 2024 and is forecast to a readjusted size of US$ 388 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-08-29
Pages: 142
The global market for Insulin Needle-free Injection Pen was valued at US$ 272 million in the year 2024 and is projected to reach a revised size of US$ 388 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-08-29
Pages: 99
The global Insulin Needle-free Injection Pen market is projected to grow from US$ 272 million in 2024 to US$ 388 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-29
Pages: 175
The global Insulin Needle-free Injection Pen market was valued at US$ 286 million in 2025 and is anticipated to reach US$ 406 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 130
The global Insulin Needle-free Injection Pen market size was US$ 286 million in 2025 and is forecast to reach a readjusted size of US$ 406 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 108
The global Insulin Needle-free Injection Pen market is projected to grow from US$ 286 million in 2025 to US$ 406 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 176
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database